Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies

被引：0

作者：

Gong, Inna Y. ^{[1
]}

Rafinejad-Farahani, Bahar ^{[2
]}

Majeed, Haris ^{[2
]}

Soto, Mark ^{[3
]}

Conti, Rena M. ^{[4
]}

Unger, Joseph M. ^{[5
]}

Guerra, Carmen E. ^{[6
]}

Rosenthal, Meredith ^{[3
]}

Rodin, Danielle ^{[7
]}

机构：

[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[2] Princess Margaret Canc Ctr, Global Canc Program, Toronto, ON, Canada

[3] Harvard T H Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA

[4] Boston Univ, Questrom Sch Business, Dept Markets Publ Policy & Law, Boston, MA USA

[5] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[6] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol & Oncol,Div Gen Med,Hosp Univ Penn, Philadelphia, PA USA

[7] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada

来源：

关键词：

D O I：

10.1182/blood-2024-206450

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5101 / 5101

页数：1